BioSpace News Archive

Sengenics, the Functional Proteomics Company, announced the appointment of Daniel Tan as Chief Financial Officer and Mark D. Quigley as Vice President of Global Sales and Marketing.

‘4S’ SEASUNBIO SMART SHIELD SYSTEM has been launched in SNU campus as the first mobile COVID-19 diagnostic center in Korea

The Company sees increased technology usage across its installed base and anticipates enrolling to at least 1500 cases by the end of 2021

MIMEDX Group, Inc. (NASDAQ: MDXG) (“MIMEDX” or the “Company”), an industry leader in utilizing amniotic tissue as a platform for regenerative medicine, today urged shareholders to consider several key questions about Prescience Point’s interests, motivations and actions regarding the disruptive proxy fight it is waging to gain undue influence over the MIMEDX Board of Directors

Releviate™ Therapeutics, a bio-pharmaceutical company addressing the needs of patients suffering from neuropathic pain, today welcomes Jennifer Maynard to its scientific advisory board.

FineHeart S.A a preclinical medical device company that has developed the ICOMS FLOWMAKER®, an Implantable Cardiac Output Management System designed to address the unmet need of patients suffering from severe heart failure, today announced the successful, simple, and breakthrough implantation and removal of its device in a 90-day in-vivo trial.

LLC established 2018/Germ Shield Pro™ Traditional disinfectants have great limitations. Once a disinfectant is applied to surfaces, they are active in killing germs for up to 10 minutes called (Dwell time)

Certilytics, Inc. today announced it will showcase its AI-powered data warehousing and predictive analytics solutions at this year’s Business Group on Health annual conference, a gathering of the nation’s largest and most forward-looking employers, including 74 Fortune 100 companies

Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today it will release its first-quarter 2021 results on Thursday, May 13, 2021, after the market close.

Quartesian, a multinational Clinical Research Organization serving the biopharmaceutical and medical device industries, announced that they have deployed Medrio’s cloud-based EDC platform for 265 clinical studies world-wide.